• Home Page
• About the Irish Medicines Formulary
  • Privacy Statement
  • Terms & Conditions
• Your Account
  • Create An Account
  • Login To Your Account
• Irish Medicines Formulary
  • 1. Gastro-Intestinal Drugs
    • 1.1.Gastric, Duodenal Ulceration
      • 1.1.1.Proton Pump Inhibitors
      • 1.1.2.H2-Antagonists
      • 1.1.3.Prostaglandin Analogues
      • 1.1.4.Chelates, Complexes
    • 1.2.Dyspepsia, GORD
      • 1.2.1.Metallic Salts
      • 1.2.2.Compound Alginates
    • 1.3.Antispasmodics
    • 1.4.Anti-Diarrhoeals
      • 1.4.1.Drugs Affecting Gastric Motility
      • 1.4.2.Rehydration, Fluids, Electrolytes
    • 1.5.Constipation, Laxatives
      • 1.5.1.Stimulant Laxatives
      • 1.5.2.Bulk Forming Laxatives
      • 1.5.3.Osmotic Laxatives
      • 1.5.4.Opioid-Induced Constipation
      • 1.5.5.Drugs Acting on Serotonin Receptors
    • 1.6.Chronic Bowel Disorders
      • 1.6.1.Corticosteroids (GI)
      • 1.6.2.Aminosalicylates (GI)
      • 1.6.3.Drugs Affecting Immune Response (GI)
    • 1.7.Anal and Rectal Disorders
      • 1.7.1.Haemorrhoids, Anal Fissure
      • 1.7.2.Haemorrhoidals, with Corticosteroids
    • 1.8.Drugs Affecting GI Secretions
      • 1.8.1.Biliary Agents
      • 1.8.2.Bile Acid Sequestrants
      • 1.8.3.Pancreatic Enzymes
  • 2. Cardiovascular Drugs
    • 2.1.Hypertension, Heart Failure
      • 2.1.1.Angiotensin Converting Enzyme Inhibitors (ACEIs) and Combinations
      • 2.1.2.Angiotensin II Antagonists (AIIAs, ARBs) and Combinations
      • 2.1.3.Renin Inhibitors and Combinations
      • 2.1.4.Alpha-Blockers
      • 2.1.5.Centrally Acting Antihypertensives
      • 2.1.6.Adrenergic Neurone Blockers
      • 2.1.7.Beta-Blockers and Combinations
    • 2.2.Calcium Channel Blockers, Nitrates, Other Antianginals
      • 2.2.1.Calcium Channel Blockers
      • 2.2.2.Potassium Channel Openers
      • 2.2.3.Nitrates
      • 2.2.4.Pulmonary Arterial Hypertension (PAH), Idiopathic Pulmonary Fibrosis (IPF)
      • 2.2.5.Peripheral Vascular Disorders
      • 2.2.6.Miscellaneous Cardiac Preparations
    • 2.3.Lipid Regulating Drugs
      • 2.3.1.Anion Exchange Resins
      • 2.3.2.Ezetimibe
      • 2.3.3.Fibrates
      • 2.3.4.Omega-3-Fatty Acids
      • 2.3.5.Statins, Statin Combinations
    • 2.4.Sympathomimetics
    • 2.5.Antiarrhythmics
      • 2.5.1.Class Ia Antiarrhythmics
      • 2.5.2.Class Ib Antiarrhythmics
      • 2.5.3.Class Ic Antiarrhythmics
      • 2.5.4.Class II Antiarrhythmics
      • 2.5.5.Class III Antiarrhythmics
      • 2.5.6.Class IV Antiarrhythmics
      • 2.5.7.Class V Antiarrhythmics
      • 2.5.8.Other Antiarrhythmics
    • 2.6.Anticoagulants, Antiplatelets, Antithrombotics
      • 2.6.1.Heparin, Heparin Flush Solutions, Heparinoids
      • 2.6.2.Synthetic Activated Factor X (Xa) Inhibitors
      • 2.6.3.Direct Thrombin Inhibitors, Reversal Agents
      • 2.6.4.Heparin Antagonists
      • 2.6.5.Oral Anticoagulants
      • 2.6.6.Antiplatelets Excluding Heparin
      • 2.6.7.Non-Steroidal Antiplatelets, Aspirin
      • 2.6.8.Other Antiplatelets
      • 2.6.9.Antithrombotics, Enzymes and Proteins
    • 2.7.Anti-Fibrinolytics and Haemostatics
    • 2.8.Positive Inotropes
      • 2.8.1.Cardiac Glycosides
      • 2.8.2.Phosphodiesterase Inhibitors
    • 2.9.Diuretics
      • 2.9.1.Carbonic Anhydrase Inhibitors
      • 2.9.2.Loop Diuretics
      • 2.9.3.Osmotic Diuretics
      • 2.9.4.Potassium-Sparing Diuretics
      • 2.9.5.Thiazides
      • 2.9.6.Aldosterone Antagonists
  • 3. Central Nervous System Drugs
    • 3.1.Antiepileptics
      • 3.1.1.Barbiturates
      • 3.1.2.Benzodiazepine Antiepileptics
      • 3.1.3.GABAergic Drugs
      • 3.1.4.Hydantoins
      • 3.1.5.Carboxamides
      • 3.1.6.Miscellaneous Antiepileptics
    • 3.2.Antipsychotics and Antimanics
      • 3.2.1.Phenothiazines
      • 3.2.2.Other Typical Antipsychotics
      • 3.2.3.Atypical Antipsychotics
      • 3.2.4.Antimanic Drugs
    • 3.3.Antidepressants and Anxiolytics
      • 3.3.1.Tricyclic, Tetracyclic Antidepressants
      • 3.3.2.Monamine Oxidase Inhibitors
      • 3.3.3.SSRIs, SNRIs
      • 3.3.4.Other Antidepressants
      • 3.3.5.Benzodiazepine Anxiolytics
    • 3.4.Hypnotics
      • 3.4.1.Benzodiazepine Hypnotics
      • 3.4.2.Zolpidem, Zopiclone
      • 3.4.3.Other Drugs Used In Sleep Disorders
    • 3.5.Parkinson's Disease, Restless Legs Syndrome
      • 3.5.1.Dopaminergics Used In Parkinson's Disease
      • 3.5.2.Levodopa
      • 3.5.3.Selective MAOIs
      • 3.5.4.Reversible COMT Inhibitors
      • 3.5.5.Antimuscarinics
    • 3.6.Multiple Sclerosis, Motor Neurone Disease
      • 3.6.1.Multiple Sclerosis (MS)
      • 3.6.2.Motor Neurone Disease (MND)
    • 3.7.Dementia
      • 3.7.1.Cholinesterase Inhibitors
      • 3.7.2.Memantine
    • 3.8.Nausea and Vomiting, Vertigo, Motion Sickness
      • 3.8.1.Meniere's Disease
      • 3.8.2.Neurokinin Receptor Antagonists
      • 3.8.3.Antihistamines, Antispasmodics
      • 3.8.4.5-HT3 Antagonists
      • 3.8.5.Propulsives
      • 3.8.6.Droperidol
    • 3.9.CNS Stimulants, Treatment of ADHD
  • 4. Analgesics, Anti-Inflammatories, Musculoskeletal Disorders
    • 4.1.Migraine
      • 4.1.1.Analgesics, Anti-Emetics
      • 4.1.2.Acute Migraine, 5HT1-Agonists
      • 4.1.3.Migraine Prophylaxis
    • 4.2.Analgesia
      • 4.2.1.Non-Opioid Analgesics
      • 4.2.2.Opioid Analgesics
      • 4.2.3.Other Analgesics
    • 4.3.Neuromuscular Disorders
      • 4.3.1.Skeletal Muscle Relaxants
      • 4.3.2.Myasthenia gravis
    • 4.4.Rheumatic Disease, Anti-Inflammatories, Gout
      • 4.4.1.Drugs Suppressing Rheumatic Disease Process
      • 4.4.2.Non-Steroidal Anti-Inflammatories (NSAIDs), (Non-Selective)
      • 4.4.3.Non-Steroidal Anti-Inflammatories (NSAIDs), (Selective)
      • 4.4.4.Osteoarthritis, Soft Tissue Disorders
      • 4.4.5.Gout, Cytotoxic Hyperuricaemia
    • 4.5.Neuropathic Pain
  • 5. Respiratory, Allergic Disorders
    • 5.1.Asthma, COPD
      • 5.1.1.Adrenoreceptor (Beta-2) Agonist Bronchodilators
      • 5.1.2.Antimuscarinic Bronchodilators
      • 5.1.3.Adrenoreceptor (Beta-2) Agonist, Antimuscarinic Combinations
      • 5.1.4.Xanthines
      • 5.1.5.Other Drugs Used In Obstructive Airway Disease
      • 5.1.6.Devices, Nebuliser Diluents
    • 5.2.Respiratory Corticosteroids and Combinations
    • 5.3.Respiratory Leukotriene Receptor Antagonists
    • 5.4.Other Respiratory System Products
    • 5.5.Mucolytics
    • 5.6.Cough, Cold and Flu
    • 5.7.Anti-Allergic Drugs
      • 5.7.1.Sedating Antihistamines
      • 5.7.2.Non-Sedating Antihistamines
      • 5.7.3.Other Drugs Used In Allergic Disorders
    • 5.8.Allergic Emergencies
  • 6. Ear, Nose, Oropharynx
    • 6.1.Ear
      • 6.1.1.Anti-Infectives, Anti-Inflammatories
      • 6.1.2.Wax Removal, Ear Pain
    • 6.2.Nose
      • 6.2.1.Rhinitis
      • 6.2.2.Nasal Staphylococci
    • 6.3.Oropharyngeal Preparations
  • 7. Ophthalmology
    • 7.1.Glaucoma
      • 7.1.1.Topical Beta-Blockers
      • 7.1.2.Carbonic Anhydrase Inhibitors
      • 7.1.3.Prostaglandin Analogues
      • 7.1.4.Sympathomimetics
      • 7.1.5.Miotics
    • 7.2.Anti-Infective Eye Preparations
    • 7.3.Ophthalmic Corticosteroids, Anti-Inflammatories, Antihistamines
    • 7.4.Ocular Lubricants
    • 7.5.Anaesthetics, Mydriatics, Diagnostics
      • 7.5.1.Topical Anaesthetics
      • 7.5.2.Mydriatics, Cycloplegics
      • 7.5.3.Ophthalmic Diagnostics
    • 7.6.Other Ophthalmologicals
  • 8. Obstetrics, Gynaecology, Urological Disorders
    • 8.1.Obstetrics
      • 8.1.1.Prostaglandins, Oxytocics
      • 8.1.2.Myometrial Relaxants
    • 8.2.Family Planning
      • 8.2.1.Combined Hormonal Contraceptives
      • 8.2.2.Transdermal
      • 8.2.3.Progestogen Only
      • 8.2.4.Long-Acting Contraceptives
      • 8.2.5.Emergency Contraception
      • 8.2.6.Termination of Pregnancy
    • 8.3.Vaginal, Vulval Infections
      • 8.3.1.Fungal Infections
      • 8.3.2.Other Infections
    • 8.4.Urological Disorders
      • 8.4.1.Benign Prostatic Hyperplasia (BPH)
      • 8.4.2.Erectile Dysfunction, Premature Ejaculation
      • 8.4.3.Urinary Incontinence
      • 8.4.4.Urinary Alkalinisers, Urolithiasis
      • 8.4.5.Dialysis
  • 9. Infectious Diseases
    • 9.1.Antibacterials
      • 9.1.1.Penicillins
      • 9.1.2.Cephalosporins, Carbepenems, Monobactams, Other Cephalosporins
      • 9.1.3.Aminoglycosides
      • 9.1.4.Macrolides
      • 9.1.5.Quinolones
      • 9.1.6.Tetracyclines
      • 9.1.7.Anaerobic Infections
      • 9.1.8.Drugs Used In Urinary Tract Infections
      • 9.1.9.Other Antibacterials, Enzymes
    • 9.2.Antifungals
    • 9.3.Antivirals Used In HIV Infection
      • 9.3.1.Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (HIV)
      • 9.3.2.Protease Inhibitors (HIV)
      • 9.3.3.Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (HIV)
      • 9.3.4.Other Antiretrovirals (HIV)
    • 9.4.Antivirals Used In Other Viral Infections
      • 9.4.1.Herpes, CMV Infection
      • 9.4.2.Viral Hepatitis
      • 9.4.3.Influenza
    • 9.5.Pharmacokinetic Enhancers
    • 9.6.Antiprotozoals
      • 9.6.1.Antimalarials
      • 9.6.2.Other Antiprotozoals
    • 9.7.Tuberculosis, Leprosy
    • 9.8.Infestations
  • 10. Dermatology
    • 10.1.Acne, Rosacea, Actinic Keratosis
      • 10.1.1.Topical Retinoids and Related Compounds
      • 10.1.2.Topical Antibacterials Used In Acne
      • 10.1.3.Benzoyl Peroxide, Azelaic Acid
      • 10.1.4.Other Topicals Used In Acne, Rosacea
      • 10.1.5.Oral Acne Treatments
      • 10.1.6.Photodamage, Actinic Keratosis
    • 10.2.Topical Anti-Infectives
      • 10.2.1.Topical Antibacterials
      • 10.2.2.Topical Antifungals
      • 10.2.3.Topical Antivirals
    • 10.3.Emollients, Barriers, Topical Antipruritics
    • 10.4.Topical Corticosteroids And Combinations
    • 10.5.Eczema, Psoriasis, Scalp Disorders
    • 10.6.Warts, Corns, Calluses
    • 10.7.Scabies, Head Lice
    • 10.8.Miscellaneous Dermatologicals
    • 10.9.Wound Care
  • 11. Endocrinology
    • 11.1.Systemic Corticosteroids
      • 11.1.1.Glucocorticoids
      • 11.1.2.Replacement Therapy
    • 11.2.Drugs Used in Diabetes
      • 11.2.1.Sulphonylureas
      • 11.2.2.Biguanides
      • 11.2.3.PPAR-Gamma Agonists
      • 11.2.4.DPP-4 Inhibitors
      • 11.2.5.SGLT-Inhibitors
      • 11.2.6.GLP-1 Agonists
      • 11.2.7.Other Antidiabetic Drugs Excluding Insulin
    • 11.3.Insulin
    • 11.4.Treatment of Hypoglycaemia
    • 11.5.Thyroid, Antithyroid Hormones
      • 11.5.1.Thyroid Hormones
      • 11.5.2.Antithyroid Drugs
    • 11.6.Hypothalamic and Pituitary Hormones, Anti-Oestrogens
      • 11.6.1.Gonadotrophins Used In Infertility
      • 11.6.2.Growth Hormone
      • 11.6.3.Growth Hormone Antagonists
      • 11.6.4.Vasopressin Analogues
      • 11.6.5.Vasopressin Antagonists
      • 11.6.6.Anti-Oestrogens
    • 11.7.Sex Hormones
      • 11.7.1.Male Sex Hormones, Androgens
      • 11.7.2.Male Sex Hormones, Anti-Androgens
      • 11.7.3.Female Sex Hormones, Progestogens
      • 11.7.4.Female Sex Hormones, Oestrogens, HRT
    • 11.8.Drugs Affecting Bone Metabolism
      • 11.8.1.Bisphosphonates
      • 11.8.2.Other Drugs Affecting Bone Metabolism
    • 11.9.Other Endocrine Drugs
  • 12. Immunology, Vaccines
    • 12.1.Active Immunisation
    • 12.2.Immunoglobulins
      • 12.2.1.Normal
      • 12.2.2.Specific
      • 12.2.3.Anti-D
      • 12.2.4.Interferons
    • 12.3.Diagnostic Testing
  • 13. Oncology, Immunosuppression
    • 13.1.Cytotoxic Drugs
      • 13.1.1.Alkylating Agents
      • 13.1.2.Cytotoxic Antibiotics
      • 13.1.3.Antimetabolites
      • 13.1.4.Plant Alkaloids, Other Natural Products
      • 13.1.5.Platinum Compounds
      • 13.1.6.Protein Kinase Inhibitors
      • 13.1.7.Monoclonal Antibodies
      • 13.1.8.Other Antineoplastics
    • 13.2.Drugs Affecting Immune Response
      • 13.2.1.Immunosuppressants
      • 13.2.2.Radiopharmaceuticals
      • 13.2.3.Interferons
      • 13.2.4.Immunostimulants
    • 13.3.Sex Hormones and Hormone Antagonists In Malignancy
      • 13.3.1.Breast Cancer
      • 13.3.2.Prostate Cancer
      • 13.3.3.Somatostatin Analogues
  • 14. Anaesthesia
    • 14.1.General Anaesthesia
      • 14.1.1.Muscle Relaxants
      • 14.1.2.Opioids In Anaesthesia
      • 14.1.3.Other Anaesthetic Adjuncts
      • 14.1.4.Inhalation Anaesthetics
      • 14.1.5.Other General Anaesthetics
      • 14.1.6.Malignant Hyperthermia
    • 14.2.Local Anaesthesia
  • 15. Toxicology
    • 15.1.Specific Substance Antagonists
      • 15.1.1.Benzodiazepines
      • 15.1.2.Cyanide
      • 15.1.3.Iron
      • 15.1.4.Lead
      • 15.1.5.Opiates
      • 15.1.6.Paracetamol
      • 15.1.7.Potassium
      • 15.1.8.Ethylene Glycol
    • 15.2.Detoxifying Agents Used For Antineoplastic Treatment
    • 15.3.Dependence
      • 15.3.1.Alcohol Dependence
      • 15.3.2.Smoking Cessation
      • 15.3.3.Opiate Dependence
  • 16. Haematology, Obesity, Metabolic Disorders
    • 16.1.Haematology
      • 16.1.1.Hypoplastic, Haemolytic, Renal Anaemias
      • 16.1.2.Megaloblastic Anaemias
      • 16.1.3.Neutropenia
      • 16.1.4.Platelet Disorders
      • 16.1.5.Drugs Used To Mobilise Stem Cells
      • 16.1.6.Plasma Substitutes, Protein Fractions
    • 16.2.Obesity
    • 16.3.Minerals, Vitamins, Dietary Supplements
      • 16.3.1.Calcium
      • 16.3.2.Iron, Folic Acid Combinations
      • 16.3.3.Magnesium
      • 16.3.4.Potassium
      • 16.3.5.Zinc
      • 16.3.6.Vitamin B Group
      • 16.3.7.Vitamin C
      • 16.3.8.Vitamin D, Analogues
      • 16.3.9.Vitamin K
    • 16.4.Multivitamin Preparations
    • 16.5.Metabolic Disorders